Tag: Columns

What to Read Next

Read about our columnists’ most- and least-favorite stocks as they make their choices.

Chinese households are losing faith in the nation’s future. Unless Beijing can reassure them, they could drag down the entire ...

Washington has laid the seeds of a crisis that Wall Street can no longer ignore.

In its eagerness to focus on snacks, Kellogg hasn’t provided a convincing growth plan for its cereal spinoff.

Rising costs of repairs, litigation and more are hitting the bottom lines of insurance companies.

Workers in some sectors are still leaving jobs at a higher rate than before the pandemic in a sign that ...

What to Read Next

Rates are still rising. The economy will be held back by the need to shore up highly indebted companies.

Large drug companies need innovation to deal with the drug-pricing law. That is a boon to smaller biotech firms.